AI-generated analysis. Always verify with the original filing.
Processa Pharmaceuticals, Inc. terminated its Binding Term Sheet dated June 17, 2025, on February 12, 2026, under Item 1.02. This disclosure informs investors of the end of a previously material definitive agreement.
Event Type
Disclosure
Mandatory
Variant
8-K
Termination of a Material Definitive Agreement. On February 12, 2026, Processa Pharmaceuticals, Inc.’s (the “Company”) Binding Term Sheet dated June 17, 2025 (t
. Financial Statements and Exhibits. Exhibit Index Exhibit No. Exhibit Description 104 Cover Page Interactive Data File (the cover page Interactive Data File is